Search clinical trials for: GSK1070806

Total 10 results

University of Birmingham
GlaxoSmithKline; University Hospital Birmingham

Completed

A Clinical Trial of Antibody GSK1070806 in the Treatment of Patients With Moderate to Severe Crohn's Disease (CDAID)

Crohn Disease

United Kingdom
GlaxoSmithKline

Not yet recruiting

Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis. (AtDvance)

Dermatitis, Atopic

United States, Germany, Spain, France, Italy, Japan, China, Argentina, Greece, Czechia, Korea, Republic of, Panama, Bulgaria, Canada, Poland, Mexico, Thailand
GlaxoSmithKline

Completed

Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis

Dermatitis, Atopic

United States, Canada
GlaxoSmithKline

Terminated

Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of GSK1070806 for the Prevention of Delayed Graft Function (DGF) in Adult Subjects After Renal Transplantation

Kidney Transplantation (Status Post)

United Kingdom, Spain
GlaxoSmithKline

Completed

First Time in Human Study of Intravenous Interleukin-18 Antibody (A18110040)

Inflammatory Bowel Diseases

United Kingdom
Cambridge University Hospitals NHS Foundation Trust

Unknown

Anti IL-18 (GSK1070806) in Behcet's Disease

Behcet's Disease

United Kingdom
GlaxoSmithKline

Recruiting

A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis

Dermatitis, Atopic

Spain, Bulgaria, Germany, Korea, Republic of, Canada, Argentina, China, United States, Poland, Italy, Czechia, Japan, Panama, Greece, Thailand, France, Mexico
Seoul National University Hospital

Not yet recruiting

Appropriate Dosage of Vasopressor in Neonates and Infants

Hypotension | Intraoperative Complications | Neonatal Hypotension
GlaxoSmithKline

Completed

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic of GSK1070806 After a Single Intravenous Dose in Healthy Male and Female Caucasian, Chinese and Japanese Participants Aged 18 to 65 Years of Age Inclusive

Dermatitis, Atopic

United States
GlaxoSmithKline

Completed

Investigate the Efficacy and Safety of GSK1070806 in Obese Subjects With T2DM (T2DM)

Diabetes Mellitus

Spain, United Kingdom

Search clinical trials for: GSK1070806

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations